Top Banner
3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI Project Lead Psychosis Clinical Academic Group (CAG) 1 st July 2015
64

IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Sep 14, 2018

Download

Documents

duonghanh
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

3 South London and Maudsley (SLaM)

IAPT-SMI Demonstration Site for Psychosis

Dr Louise Johns

Consultant Clinical Psychologist

IAPT-SMI Project Lead

Psychosis Clinical Academic Group (CAG)

1st July 2015

Page 2: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

NICE 2009/2014

• Offer CBT to all people

with schizophrenia

• Offer family

intervention to families

who live with or are in

close contact with the

service user

Page 3: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

69% of Trusts have funding

challenges for providing

access to psychological

therapies for people with a

diagnosis of schizophrenia

94% have encountered obstacles in making psychological therapies available, including insufficient skilled staff

Page 4: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

“Research has led to a range of

evidence-based psychological

treatments. We know much more

about ‘what works’ than we used

to. . . The committed individuals

who went into the mental health

profession to improve lives should

be helped to do exactly that.”

Schizophrenia Commission

Prof Sir Robin Murray

Page 5: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

“I always asked for some

kind of psychological

therapy or talking therapy

but was told, no, it was too

dangerous. I had to wait 20

years for something that

was the most beneficial

thing. [Therapy] has

changed my life basically.”

Dolly Sen,

Service User Consultant

Talking to Norman Lamb MP, Minister of State, on 19 December 2012 at SLaM

Page 6: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Delays in accessing CBTp in SLaM Peters et al, 2009

(N=74)

• Mean length of illness was 8 years (range 0-32)

• Mean of 2.8 in-patient admissions (range 0-20)

Page 7: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

National Audit of Schizophrenia (2014)

‘It is clear that the numbers of service users having

access to, and actually receiving, these types of

intervention remain very low.

This needs to be addressed and has significant

funding implications.

...this is probably the largest deficit that exists in

the treatment services provided by Trusts.’

Page 8: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

National Audit of Schizophrenia (2014)

Recommendations for the Department of Health

Ensure the Increasing Access to Psychological

Therapies (IAPT) for severe mental illness

programme has the same level of support as the

existing IAPT for anxiety and depression.

This should include a national data set, indicators in

national frameworks and plans for how this could

develop.

Page 9: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Barriers to Access

• Too few therapists

• Insufficiently trained (lack of clarity on

competences)

• Lack of supervision

• No time; without specialised role

• Organisational barriers & lack of support (other

interventions prioritised; therapy a ‘luxury’)

(Shafran et al., 2009; Berry & Haddock, 2008; Haddock et al., 2014; Lobban & Jones

2010; Prytys et al., 2011)

Page 10: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Overcoming obstacles to access in

SLaM

Page 11: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

• Core population – 4 South London Boroughs 1.3 million; inner city, very high indices of psychosis and social deprivation and ethnic diversity

• Psychosis Clinical Academic Group which provides services for 7,000 people with psychosis

• All services for people with psychosis organised in 4 stage specific care pathways

• Clinical research programme focused on translational research, developing new psychological treatments

Page 12: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Predicted new cases: England and Wales

Local Authorities: Lowest, mid and SLaM boroughs

Source: Kirkbride et al, 2013, Psymaptic

Page 13: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Work in SLaM 2003-2012

• Ten point charter addressing barriers and facilitators:

– Service user involvement

– Therapy quality criteria and staff training

– Data gathering, data systems and outcomes

– Care pathways, ensuring integrated effective psychological therapies in Early Intervention & Recovery pathways

Page 14: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Historical service data

Page 15: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Graph 1 Psychotic symptoms reduction [voices (effect size: .52) and delusions

(effect size: .75)] following therapy, maintained at follow-up (effect sizes: .44 & .82)

(all significant at p<.001)*.

*Linear mixed model analyses include mid-therapy

scores and are based on 248 individuals for voices;

302 for delusions (but only 25% have follow-up assessment)

Page 16: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Graph 2 Emotional problems reduction [anxiety (effect size: .44) and depression

(effect size: .51)] maintained at follow-up (effect sizes: .29 & .34) (all significant at

p < .001)*.

*Linear mixed model analyses include mid-therapy

scores and are based on 360 individuals for depression;

362 for anxiety (but only 24% have follow-up assessment)

Page 17: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Graph 3 General distress reduction [CORE-10 (effect size: .61) and increase in life

satisfaction (effect size: .49)] maintained at follow-up (effect sizes: .47 & .47) (all

significant at p < .001)*.

*Linear mixed model analyses include mid-therapy scores and

are based on 180 individuals for CORE; 361 for MANSA (but only

36% have follow-up assessment for CORE; 23% for MANSA)

Page 18: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

IAPT-SMI in SLaM

Page 19: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Selection of Demonstration Sites by

Open Competition: criteria

• Delivering evidence-based psychological therapies

• Therapists with appropriate competences

• Have strategic approach, which is replicable

• Collecting outcome data routinely and effectively

(access to historical data)

• Provision of training and supervision

• Overcoming barriers to implementation: e.g. senior

management ‘buy-in’; ring-fenced time

Page 20: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Our aims

• Increase access by 50%

• Pilot outcome measures, including sessional

measure

• Improve completion rates to 95% minimum

• Provide a clinically and cost-effective service

Page 21: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

SLaM Psychosis Demonstration site:

Increasing access in two care pathways

Promoting Recovery Pathway Promoting Recovery Pathway

Early Intervention Pathway

Page 22: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI
Page 23: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

What IAPT-SMI offers: CBTp CBT for psychosis:

• Weekly or fortnightly individual 1 hour sessions

• 6-9 months therapy

• Therapists receive weekly-fortnightly group supervision Suitability criteria:

• F20 diagnosis (schizophrenia spectrum)

• distressing positive symptoms of psychosis OR

• secondary emotional disturbances / sense-making & recovery

work

• not predominantly negative symptoms

• motivated to attend

Page 24: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

What IAPT-SMI offers: FIp FI for psychosis:

• Fortnightly 1 hour sessions with client and carer(s)

• Up to ten sessions, over a period of 3-9 months

• Therapy delivered by two trained therapists

• Usually delivered at home

• Therapists receive weekly-fortnightly group supervision Suitability criteria:

• F20 spectrum diagnosis

• In close contact with an ‘informal caregiver’ (approx. 10 plus

hours face to face or living with)

• Need carer and service user agreement

Page 25: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Pre

PSYRATS – Voices & Beliefs

WEMWBS

WSAS

EQ-5D

Short CHOICE

CORE-10

Brief IPQ

Measures Feedback

3-month

PSYRATS – Voices & Beliefs

WEMWBS

WSAS

EQ-5D

Short CHOICE

CORE-10

Brief IPQ

Measures Feedback

Satisfaction with therapy & PEQ

Post

PSYRATS – Voices & Beliefs

WEMWBS

WSAS

EQ-5D

Short CHOICE

CORE-10

Brief IPQ

Measures Feedback

Satisfaction with therapy & PEQ

Short CHOICE weekly

IAPT-SMI:

CBT assessments

Page 26: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Pre

Experience of caregiving inventory

WEMWBS

DASS-21

CORE-10

IPQ carer version

Confidant question

Measures Feedback

Post

Experience of caregiving inventory

WEMWBS

DASS-21

CORE-10

IPQ carer version

Confidant question

Measures Feedback

Satisfaction with therapy

Sessional satisfaction measure

IAPT-SMI:

Carer assessments

Page 27: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI
Page 28: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

• Overall, perceived as helpful (Mean 6.7-7.0, SD 2.0-2.3)

• Perceived more positively by older clients, but

unrelated to symptom severity, gender or ethnicity

• Majority (>90%) rated as neutral or helpful; length,

emotional content & repetition identified as less helpful

• Comments: ‘used my brain’; ‘made me think’; ‘helped

explain’; ‘helped identify an area to work on’; ‘good to

get things off my chest’

Satisfaction with Measures

Page 29: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Therapy was life-changing and empowering. I have a better understanding of my problems, particularly the triggers and contributions to them.

Therapy has helped me to deal with my anxiety and paranoid thoughts. I am confident I can cope if I have any negative thoughts in the future. I now feel able to move forward with my life

Therapy has been a fantastic experience. I now have a better understanding of why I hear voices and how to cope with them. I now feel less stressed and much happier in myself.

It was helpful to learn about

my thinking, considering

alternative perspectives and

seeing the positive sides of a

situation.

Page 30: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

IAPT-SMI Family feedback

‘For the family therapy, I think it was to have

a space. Where {my son} and I could

actually verbalise our concerns… in a space

where it wasn’t, it wouldn’t lead to an

argument, or hurt or upset, because it was

a, I am saying this so I can, so we can find a

solution to it.’

Page 31: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI
Page 32: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI
Page 33: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

My experience of therapy

Page 34: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Progress and 24-month outcomes

Further detail in:

Jolley S et al (2015), Behaviour Research and Therapy, 64, 24-30

Page 35: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Increased access - referrals

2011 Projected Achieved per annum

Total Increase Total %inc PA %inc PA

CBT 106 50 156 47% 288 172%

FI 15 10 25 67% 38 153%

Both 121 60 181 50% 326 169%

Page 36: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Speed of access

Mean waiting times (days)

Months Referred to

assessed

Assessed to

offered

therapy

Total

%

reduction

in waiting

times

6 45 38 83 40%

12 43 49 92 33%

24 38 48 86 38%

Page 37: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Male BME

Female BME

0%

20%

40%

60%

80%

100%

EI ≤35 PR TOTAL

Male BME 93% 87% 89%

Male non-BME 86% 94% 92%

Female BME 88% 89% 89%

Female non-BME 100% 88% 91%

% co

mpl

etin

g

Treatment completers (n=211) by age and demographics

Equity of access

Page 38: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Completion of measures

• Paired completion – 96% for 5+ sessions; 78% for

drop-out (<5 sessions)

• DH minimum dataset – feasible & acceptable

• FI assessments – feasible & acceptable

• Completion regime: Pre, Mid, Post, no Mid for FI

• Sessional CHOICE: feasible, acceptable and

essential for paired completion rates

Page 39: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=58) PR (n=145)

PRE 5.00 4.21

POST 6.70 5.81

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

8.00

Service user-reported wellbeing: CHOICE (p<.001; ES 0.8, 0.7)

Page 40: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=46) PR (n=134)

PRE 42.43 36.77

POST 51.70 44.99

0.00

10.00

20.00

30.00

40.00

50.00

60.00

Service user-reported wellbeing: WEMWBS (p<.001; ES 0.8, 0.7)

Page 41: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=44) PR (n=125)

PRE 16.90 21.22

POST 12.10 16.83

0.00

5.00

10.00

15.00

20.00

25.00

Service user-reported impact on functioning: WSAS

(EI: p=.002, ES 0.5; PR: p<.001, ES 0.5)

Page 42: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=47) PR (n=128)

PRE 15.81 17.92

POST 10.34 13.16

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

18.00

20.00

Service user-reported distress:CORE-10 (p<.001; ES 0.6)

Page 43: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=13) PR (n=60)

PRE 21.38 23.98

POST 11.54 19.28

0.00

5.00

10.00

15.00

20.00

25.00

30.00

Service user-reported voices: PSYRATS (EI: p=.007, ES 1.1; PR: p<.001; ES 0.5)

Page 44: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

EI (n=13) PR (n=70)

PRE 13.92 13.63

POST 7.10 8.30

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

Service user-reported beliefs: PSYRATS(EI: p=.002, ES 1.4; PR: p<.001; ES 0.85)

Page 45: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

IAPT-SMI Demonstration Site for

Psychosis: Cost-Effectiveness Analyses

Prof Paul McCrone Professor of Health Economics

Centre for the Economics of Mental and Physical Health

(CEMPH)

King's College London

Institute of Psychiatry, Psychology & Neuroscience

Page 46: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Methods • Therapy costs estimated using PSSRU figures (Curtis,

2013)

• Bed days and crisis team episodes recorded over

therapy period and for estimated for period of same

length before therapy

• Costs based on NHS Reference Costs

• Health-related quality of life measured with EQ5D

before, during and after therapy

• Change in employment status recorded

Page 47: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Crisis Team Costs

Page 48: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Bed Costs

Page 49: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Total Costs by Pathway

Page 50: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Health-Related Quality of Life

Page 51: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Employment and Activity

Page 52: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Economic summary

• Increased costs of therapy offset by

reduced inpatient and crisis team costs

• Improvements in quality of life

• Improvements in employment status

• Indications of cost-effectiveness

• Future controlled studies required

Page 53: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Competence,

Training and

Supervision

Page 54: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

IAPT-SMI: Competence Framework for Psychological Interventions for people with Psychosis / Bipolar Disorder (Roth & Pilling, 2013)

• Modular training outline

• From awareness supervision & service change

• www.ucl.ac.uk/CORE

Page 55: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

• Individualised and formulation based, but adheres to

published manuals and the CORE CBTp competence

framework (Roth and Pilling, 2013).

• Therapists are trained to competence, using assessments

of adherence and competence.

• Supervision provided weekly to fortnightly in groups of 3-6

therapists for 1.5 hours, with fortnightly to monthly

individual supervision.

• Supervisors are senior clinicians with experience of

training therapists and of providing therapy within RCTs.

CBTp in SLaM Demonstration Site

Page 56: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Training and competence summary

• Portfolio of training opportunities in psychological

therapies for psychosis, in partnership with KCL

• Span the workforce from non-clinical to

managerial/supervisory

• Academically accredited training and in-service

courses

• Short courses and modules build to an award

• Supervised practice strongly emphasised

• Supervision and support for supervisors

Page 57: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

What has the SLaM IAPT-SMI pilot demonstrated?

Page 58: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Initial investment We requested:

• Additional therapist time

• Supervision & management time

• Dedicated assessment resource

• Administrative support

We selected therapists with specific competences, or

trained them to competence, and provided close

and frequent supervision

Page 59: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Embedded in the service • In the PR pathway, therapy provision closely

aligned with, but separate from the MDT

• In the EI pathway, psychological therapy embedded

within the specialist MDT

• Representative PR client group, selected for

potential to engage with stand-alone therapy: fits

evidence base

• Specialised assessors: flexible but persistent follow

up to maintain engagement and keep attrition down

Page 60: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

The site has been able to:

• Exceed targets for increased access to therapy • Provide equity of access that reflects the diversity of

our local population • Achieve excellent completion rates on outcome

measures, with positive feedback about the assessment process

• Show significant within group pre-post improvements on the outcome measures and high satisfaction rates

• Provide health economic evidence indicating cost effectiveness

Page 61: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

What we have learnt: • NICE-recommended individual psychological therapy can

be successfully delivered in routine services

• In the SLaM demonstration site, primary facilitators were: – ring-fenced investment in competent therapy provision

– ring-fenced time for therapists to deliver therapies

– adequate supervision, training and CPD

– trained independent assessors

– established service pathways & governance structures

– strong clinical leadership & management

• Our framework is replicable to inform implementation in

other services and is now informing the Early Intervention

in Psychosis Access and Waiting Time initiative

Page 62: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

• Requires a therapist champion to lead service

development and facilitate organisational change – this

should be the initial investment

• ‘Ready’ organisations will be able to use further

investment to work towards a critical mass of supervisors

and therapists

• Can then support further workforce development

innovations (such as low intensity approaches)

• Dedicated assessment and administrative resources

makes more efficient use of therapist time and maintains

completion rates for outcomes

Rolling this out...

Page 63: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Thanks to the IAPT-SMI Project Team

Operational Group:

• Dr Louise Johns, Consultant clinical psychologist, Project lead

• Dr Suzanne Jolley, Data Lead, Lambeth Recovery Psychology lead

• Dr Miriam Fornells-Ambrojo, Clinical Psychologist, STEP, IAPT-SMI EI lead

• Dr Juliana Onwumere, FI lead, service user and carer involvement lead

• Craig Milosh, Clinical Psychologist, SHARP

• Devon Elliott, Business Intelligence Analyst, Psychosis Management Team

• Bina Sharma, Rosanna Michalczuk, Zara Kanji, Annabel Broyd and Suzanne Law, Psychology Assistants

Steering group:

• Prof Philippa Garety, Psychosis CAG Clinical Director

• Angela Morford and Garry Ellison, Service User consultants

• Roger Oliver, Carer consultant

• Dr Emmanuelle Peters, PICuP Director

• Adrian Webster, CAG Psychological Therapies lead

• Sarah Dilks, Lead Psychologist, Promoting Recovery pathway

• Dorothy Abrahams and Marlise Marshall, administrators

Page 64: IAPT SMI Demonstration site for Psychosis · 3 South London and Maudsley (SLaM) IAPT-SMI Demonstration Site for Psychosis Dr Louise Johns Consultant Clinical Psychologist IAPT-SMI

Thank you for listening

[email protected]